Evaluation of the ability of Raman spectroscopy to diagnose malignant lymphoma

Evaluation of the ability of Raman spectroscopy to diagnose malignant lymphoma - Raman spectroscopy for diagnosis of malignant lymphoma

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000031869

Enrollment

Registered

2018-06-01

Start date

2018-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

malignant lymphoma

Interventions

About 10 mL of blood is collected from healthy volunteers.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Healthy volunteers are recruited from the menber of the departments of Ophthalmology and Systems Neuroscience, Tokyo Medical and Dental University.

Exclusion criteria

Exclusion criteria: Those suffering from chronic diseases or some infectious diseases.

Design outcomes

Primary

Measure	Time frame
Human T cells, B cells, neutrophils and monocytes collected from healthy volunteers are cultured for several days to several weeks under maintenance condition or activation conditions imitating inflammatory environment. Raman spectroscopy are evaluated by Raman microscopy .	—

Countries

Japan

Contacts

Public ContactYuko Iwasaki

National University Corporation Tokyo Medical and Dental University Department of Ophthalmology

sahnya96@gmail.com03-3813-6111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026